BACKGROUND:Galactose consumption as the only carbohydrate source results in little increase in plasma glucose and insulin concentrations when compared with fasting. Lower insulin might promote endogenous lipolysis during meal absorption, which may facilitate fat loss. OBJECTIVE: The objective was to test the hypothesis that consumption of an isocaloric, isonitrogenous galactose drink will result in higher rates of lipolysis and fat oxidation than consumption of a glucose drink in obese lactating and nonlactating women. DESIGN:Seven healthy, obese, exclusively breastfeeding women and 7 healthy, obese, nonlactating women were studied on 2 occasions according to a randomized, crossover, single-blinded design. Subjects received drinks providing ≈70% of the daily estimated energy requirement, of which 60% was either glucose or galactose. The primary outcomes were the rate of appearance (Ra) of glycerol and palmitate, and the secondary outcomes were glucose Ra, milk production, energy expenditure, and substrate oxidation. RESULTS:Plasma glucose and insulin concentrations were lower (P < 0.05) and those of glycerol, palmitate, free fatty acids, and triglycerides were higher (P < 0.05) during galactose than during glucose feeding in both nonlactating and lactating women. During galactose feeding, glucose Ra was lower (P < 0.01) and glycerol, palmitate, and free fatty acid Ra were higher (P < 0.01) in both groups. During galactose feeding in all women combined, fat oxidation was higher (P = 0.01) and protein oxidation was lower (P < 0.01). Milk production, energy expenditure, and carbohydrate oxidation were similar between glucose and galactose feeding. CONCLUSIONS:Galactose consumption is associated with higher endogenous fat mobilization and oxidation during meal absorption. Long-term studies are required to determine whether galactose as an exclusive carbohydrate source would promote body fat loss in obese subjects.
RCT Entities:
BACKGROUND:Galactose consumption as the only carbohydrate source results in little increase in plasma glucose and insulin concentrations when compared with fasting. Lower insulin might promote endogenous lipolysis during meal absorption, which may facilitate fat loss. OBJECTIVE: The objective was to test the hypothesis that consumption of an isocaloric, isonitrogenous galactose drink will result in higher rates of lipolysis and fat oxidation than consumption of a glucose drink in obese lactating and nonlactating women. DESIGN: Seven healthy, obese, exclusively breastfeeding women and 7 healthy, obese, nonlactating women were studied on 2 occasions according to a randomized, crossover, single-blinded design. Subjects received drinks providing ≈70% of the daily estimated energy requirement, of which 60% was either glucose or galactose. The primary outcomes were the rate of appearance (Ra) of glycerol and palmitate, and the secondary outcomes were glucose Ra, milk production, energy expenditure, and substrate oxidation. RESULTS: Plasma glucose and insulin concentrations were lower (P < 0.05) and those of glycerol, palmitate, free fatty acids, and triglycerides were higher (P < 0.05) during galactose than during glucose feeding in both nonlactating and lactating women. During galactose feeding, glucose Ra was lower (P < 0.01) and glycerol, palmitate, and free fatty acidRa were higher (P < 0.01) in both groups. During galactose feeding in all women combined, fat oxidation was higher (P = 0.01) and protein oxidation was lower (P < 0.01). Milk production, energy expenditure, and carbohydrate oxidation were similar between glucose and galactose feeding. CONCLUSIONS:Galactose consumption is associated with higher endogenous fat mobilization and oxidation during meal absorption. Long-term studies are required to determine whether galactose as an exclusive carbohydrate source would promote body fat loss in obese subjects.
Authors: Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson Journal: N Engl J Med Date: 2005-06-12 Impact factor: 91.245
Authors: Mahmoud A Mohammad; Agneta L Sunehag; Shaji K Chacko; Amy S Pontius; Patricia D Maningat; Morey W Haymond Journal: Am J Physiol Endocrinol Metab Date: 2009-08-04 Impact factor: 4.310
Authors: Erika M Munch; R Alan Harris; Mahmoud Mohammad; Ashley L Benham; Sasha M Pejerrey; Lori Showalter; Min Hu; Cynthia D Shope; Patricia D Maningat; Preethi H Gunaratne; Morey Haymond; Kjersti Aagaard Journal: PLoS One Date: 2013-02-13 Impact factor: 3.240
Authors: Sanjeet G Patel; Jean W Hsu; Farook Jahoor; Ivonne Coraza; James R Bain; Robert D Stevens; Dinakar Iyer; Ramaswami Nalini; Kerem Ozer; Christiane S Hampe; Christopher B Newgard; Ashok Balasubramanyam Journal: Diabetes Date: 2012-11-16 Impact factor: 9.461
Authors: Carolyn M Slupsky; Xuan He; Olle Hernell; Yvonne Andersson; Colin Rudolph; Bo Lönnerdal; Christina E West Journal: Sci Rep Date: 2017-06-16 Impact factor: 4.379
Authors: Maxim D Seferovic; Mahmoud Mohammad; Ryan M Pace; Melinda Engevik; James Versalovic; Lars Bode; Morey Haymond; Kjersti M Aagaard Journal: Sci Rep Date: 2020-12-16 Impact factor: 4.379